Stockreport

Esperion Therapeutics Inc (ESPR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Sequential Quarterly Net Revenue Growth: Collaboration Revenue: $20.5 million, a 50% increase from $13.7 million in Q3 2023. Research and Development Expenses: $10. [Read more]